Please login to the form below
Spain
This page shows the latest Spain news and features for those working in and with pharma, biotech and healthcare.
GSK’s new global survey exposes lupus treatment gaps
HCPs were surveyed across France, Spain, Germany, Canada, China and Japan between July and September 2022.
Latest news
-
Sandoz to invest €50m in Austrian manufacturing facility to meet global antibiotic demand
In 2021, the company also shared that it was investing an additional 50m for sterile API production at Palafolls, Spain.
-
GSK’s shingles vaccine demonstrates at least ten-year efficacy in long-term study
Spain. The ongoing study follows participants from the phase 3 ZOE-50 and ZOE-70 clinical trials for an additional six years, in which vaccine efficacy was 97% in adults 50
-
Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
The trial will be a phase 1b/2, open-label, randomised, multi-national study in patients with first-line mPDAC and will be conducted in the US, Germany, Spain and South
-
NHS England to roll out continuous glucose monitors to all those with type 1 diabetes
Karen Baxter, vice president, UK and Ireland, Benelux, France and Spain at Dexcom, also commented: “The addition of Dexcom ONE to the NHS England drug tariff is enormous progress towards improving
-
Happify Health and Almirall launch Claro to support psoriasis patients
The digital wellness app is now available to those with the condition living in the UK, Spain and Italy. ... Almirall and Happify Health, the Intelligent Healing Company, have announced that its digital programme Claro is live and is now available to
More from news
Approximately 10 fully matching, plus 374 partially matching documents found.
Latest Intelligence
-
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
The campaign from our teams in Spain, designed to show society that there’s still plenty of life in patients with mTNBC, tackled one of the biggest challenges in cancer care: ... While in Europe, approval for priority anticancer drugs takes 180 days,
-
Assessing the impact of rarity on French HTA and pricing decisions
ATC. However, as prices of ASMR 1-3 products are freely set up to the average price in Germany, the UK, Spain and Italy, and only volume is negotiated with CEPS
-
Global leaders in digital channels
This low level of weekly channel activity contrasts significantly with users in Spain, who recorded a higher volume of interactions per user than in the other four major European countries (France,
-
Creating the urgency and drive needed to tackle antimicrobial resistance
Two other doctors who are looking to make a difference in the space and affect policy are Eduardo García-Toledano in Spain and Haileyesus Getahun in Switzerland, both of whom discussed
-
Are smart deals a clever solution to UK market access?
as Spain and Italy.
More from intelligence
Approximately 2 fully matching, plus 60 partially matching documents found.
Latest appointments
-
FCB Health Europe appoints two new senior leadership positions
Rojas will oversee the management of a team of planners in the UK, Germany and Spain.
-
STEM Healthcare bolsters its EU5 team
Enrique Cruz-Jentoft (pictured right) has joined the agency as its general manager for Spain following pharmaceutical industry experience gained from servingand MSD.
-
Minoryx Therapeutics adds to board of directors
Dr Claude Nicaise joins as an independent board member. Dr Claude Nicaise has joined Barcelona, Spain-based Minoryx Therapeutics as an independent board member.
-
Caldan Therapeutics bolsters senior team
Most recently, Dr Connolly served as scientific leader with Almirall, based in Barcelona, Spain.
-
ClinTec appoints regional manager for Spain and Portugal
Carlos Palacios joins the contract research organisation. Contract research organisation ClinTec International has appointed Carlos Palacios to the newly-created position of regional manager for Spain and Portugal. ... Palacios joins ClinTec from Merck,
More from appointments
Approximately 1 fully matching, plus 19 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
LactApp is a breastfeeding companion app which was designed in Spain and is now used by 19% of Spanish new mothers.
-
What does the future hold for clinical trial recruitment?
For example, in Spain direct approaches through social media are prohibited whereas in the UK and US this is permissible.
-
Viseven opens a new center of excellence in India
Presently, the company has specialists in more than ten countries, including the United States, Canada, Argentina, France, Spain, Germany, Poland, and Ukraine.
-
How do doctors want to engage with pharma on new products?
M3 Global Research put these questions to 1, 848 EU doctors mainly from the top five EU nations – Germany (332); France (380); Italy (266); Spain (293) and UK (318).
-
What does the future hold for Light-chain Amyloidosis?
According to recent reports, approximately 20, 000 people across the US, France, Germany, Italy, Spain and the UK live with AL amyloidosis, classified as Mayo stage IIIa or IIIb.
More from PMHub
Approximately 0 fully matching, plus 53 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- Eli Lilly announces $450m investment in US manufacturing site
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Creabilis names Catherine Moukheibir as chairman of the board
- World Health Organization releases latest set of COVID-19 guidelines
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
